Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection

Journal of Viral Hepatitis
G V PapatheodoridisE K Manesis

Abstract

We evaluated the longitudinal changes of viraemia and predictors of progression in a prospectively followed cohort of 150 untreated patients with HBeAg-negative chronic hepatitis B virus (HBV) infection. According to the first year of follow-up, 85 patients were classified into inactive carrier state and 65 into chronic hepatitis B (CHB). Serum HBV DNA levels were determined at baseline in all patients, at year-1 in carriers or last pretherapy visit in CHB patients and during alanine aminotransferase (ALT) elevations in carriers progressing to CHB. HBV DNA levels at any occasion were > or =80, > or =2000 or > or =20 000 IU/mL in 81%, 23% or 0% of carriers and 100%, 95% or 83% of CHB patients. The cumulative progression rate from carrier to CHB was 11%, 16%, 24% at 2-, 3-, 4 years and was independently associated with higher baseline ALT (always within traditional normal range) and baseline HBV DNA > or =2000 or > or =5000 IU/mL. In 12 carriers progressed to CHB, HBV DNA increased by >1 log(10) IU/mL. During 7.5 months of median follow-up, HBV DNA change > or =1 log(10) IU/mL was observed in 49% of CHB patients. In conclusion, serum HBV DNA levels are detectable in the majority of inactive HBV carriers exceeding 2000 IU/mL in on...Continue Reading

References

May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M R BrunettoH Will
Jun 1, 1995·Journal of Hepatology·K IshakR N MacSween
Feb 1, 1993·Annals of Internal Medicine·R de FranchisG Ronchi
May 29, 2001·Gastroenterology·A S LokJ H Hoofnagle
Sep 14, 2001·Journal of Viral Hepatitis·G V Papatheodoridis, S J Hadziyannis
Dec 4, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A S LokUNKNOWN Practice Guidelines Committee, American Association for the Study of Liver Diseases
Mar 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sheng-Chieh HsuJaw-Ching Wu
Apr 12, 2002·Journal of Hepatology·Michelle Martinot-PeignouxPatrick Marcellin
Jul 3, 2002·Annals of Internal Medicine·Daniele PratiGirolamo Sirchia
Nov 26, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chi-Jen ChuAnna S F Lok
Jun 25, 2003·Journal of Hepatology·Didier SamuelDaniel Vittecoq
Mar 5, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna S F LokUNKNOWN Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD)
Mar 16, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Emmet B KeeffeTeresa L Wright
May 5, 2006·Seminars in Liver Disease·Stephanos J Hadziyannis, George V Papatheodoridis
Jun 13, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Robert G Gish, Stephen A Locarnini
Jul 18, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Emmet B KeeffeTeresa L Wright
Jan 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna S F Lok, Brian J McMahon

❮ Previous
Next ❯

Citations

Jul 12, 2011·The Journal of Infectious Diseases·Henry Lik-Yuen ChanVincent Wai-Sun Wong
Jan 1, 2009·Infection and Drug Resistance·Jurriën Gp Reijnders, Harry LA Janssen
Dec 6, 2008·World Journal of Gastroenterology : WJG·George V PapatheodoridisAthanasios J Archimandritis
Sep 28, 2010·World Journal of Gastroenterology : WJG·Lee Guan LimSeng Gee Lim
Feb 19, 2014·Transactions of the Royal Society of Tropical Medicine and Hygiene·J R AndradeRosângela Teixeira
Mar 14, 2013·Expert Opinion on Medical Diagnostics·Runu Chakravarty
Jul 3, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Faisal M SanaiAyman A Abdo
Jun 26, 2012·European Journal of Internal Medicine·T StroffoliniUNKNOWN Gr.E.Ca.S. Hospitals' Collaborating Group
Sep 7, 2011·Gastroenterology Clinics of North America·Maximilian Lee, Emmet B Keeffe
Jan 5, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Federica InvernizziPietro Lampertico
Jul 20, 2010·Clinics in Liver Disease·Michelle Lai, Yun-Fan Liaw
Mar 23, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Chia-Ming ChuYun-Fan Liaw
Apr 21, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Dar-In TaiYun-Fan Liaw
Feb 12, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Yun-Fan Liaw
Oct 17, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·George V PapatheodoridisAthanasios J Archimandritis
Jan 18, 2011·Alimentary Pharmacology & Therapeutics·L CastéraV de Lédinghen
Jan 19, 2011·Internal Medicine Journal·C M N CroaghP V Desmond
Jun 23, 2011·Journal of Viral Hepatitis·A M IppolitoA Andriulli
May 25, 2010·Liver International : Official Journal of the International Association for the Study of the Liver·William Graham Earnshaw Cooksley
Jan 11, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·George V Papatheodoridis
Mar 23, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver
May 5, 2009·Journal of Hepatology·George V Papatheodoridis, Spilios Manolakopoulos
May 21, 2016·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Stijn F H RavenJim E van Steenbergen
Mar 8, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Phunchai CharatcharoenwitthayaTawesak Tanwandee
May 9, 2018·Liver International : Official Journal of the International Association for the Study of the Liver·Mohamed El KassasArnaud Fontanet
Dec 5, 2012·The Journal of International Medical Research·A E AtayH Degertekin
Jul 5, 2018·Clinical and Molecular Hepatology·San Juan López CristinaParrón Carreño Tesifón
Feb 25, 2018·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Ujjwal Sonika Shalimar
Jun 5, 2010·Expert Review of Anti-infective Therapy·James FungMan-Fung Yuen
Aug 27, 2017·BMC Gastroenterology·Faisal M SanaiKhalid I Bzeizi
Dec 29, 2020·Journal of Virological Methods·Gezahegn Mekonnen WoldemedihnAsgeir Johannessen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
G V PapatheodoridisAthanasios J Archimandritis
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Jordan J FeldE Jenny Heathcote
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Chia-Ming ChuYun-Fan Liaw
Journal of Hepatology
European Association For The Study Of The Liver
© 2021 Meta ULC. All rights reserved